埃斯弗鲁尔比芬通过阻断SERT-nNOS相互作用来产生快速开始的抗抑郁药效应
Yu-Qi Chen1, Jun-Rui Ye2, Sha-Sha Wang2,3
1College of Medicine and Health Sciences, China Three Gorges University, Yichang, 443002, China.
Acta pharmacologica Sinica
|October 9, 2025
概括
这项研究将esflurbiprofen确定为一种新的快速起作用抗抑郁药. 它通过破坏血清载体 (SERT) 和神经元氧化合成酶 (nNOS) 的相互作用而起作用,从而迅速缓解抑郁症状.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- 选择性血清素再吸收抑制剂 (SSRI) 由于5-HT1A自身受体脱敏,延迟了治疗效果.
- 血清载体 (SERT) 和神经元氧化合成酶 (nNOS) 相互作用的解离为快速开始的抗抑郁药物反应提供了一条途径.
研究的目的:
- 开发一个查系统来识别SERT-nNOS相互作用阻断剂 (SNIBs).
- 通过准SERT-nNOS相互作用来识别一种新的快速发作的抗抑郁药候选药物.
主要方法:
- 利用mbret和生物测试进行药物查.
- 在小鼠抑郁症模型 (CSDS和CRS) 中识别和测试了esflurbiprofen.
- 使用药理动力学,rs-fMRI和在背脊拉菲核 (DRN) 中的分子技术分析了效应.
主要成果:
- 埃斯弗卢尔比被确定为一个有前途的SNIB,与nNOS PDZ域结合.
- 埃斯弗鲁尔比芬剂量依赖性降低了压抑行为,并增强了紧张小鼠的神经连接.
- 埃斯弗卢比烯破坏了SERT-nNOS复合体,增加了膜SERT,并调节了DRN中的5-HT水平,增强了血清激素的发射.
结论:
- 埃斯弗卢尔比烯通过向DRN中的SERT-nNOS相互作用,显示出快速抗抑郁作用的潜力.
- 这种机制绕过了与传统的SSRI相关的延迟发病.
- 埃斯弗卢尔比烯代表了抑郁症的有前途的治疗策略.
相关概念视频
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
1.4K
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
1.4K
01:23Antidepressant Drugs: MAOIs and Other Agents
823
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
823
01:23Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
884
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
884
01:23Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
634
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
634
01:25Antidepressant Drugs: Overview
1.4K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
1.4K
01:21Drugs Affecting Neurotransmitter Release or Uptake
1.5K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.5K